story of the week
Efficacy and Safety of Atezolizumab Plus Bevacizumab vs Sorafenib as First Treatment for Patients With Unresectable Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology